GenesisCare is a global healthcare company and one of the world’s largest integrated oncology organisations. The company’s purpose is to design care experiences that get the best possible life outcomes. This is grounded in the belief that care should be focused on the individual, not the condition. GenesisCare is the world’s largest provider of radiotherapy – a vital treatment option for cancer patients – and provides patients with access to diagnostics, medical oncology, surgical oncology, radiotherapy, and novel therapies alongside the ability to participate in the latest clinical trials. With a growing research and trials program numbering more than 150 clinical trials, a contract research organisation, and global innovation programs focused on precision medicine and novel therapies, GenesisCare aims to bring new therapies to more patients in need in a more affordable way. Every year, GenesisCare clinical teams see more than 450,000 people across 350+ locations, including more than 300 locations in the U.S., 40 in Australia, 14 in the UK, and 18 in Spain. Headquartered in Sydney, Australia, the organisation employs more than 5,500 highly trained physicians, healthcare professionals and support staff across Australia, Europe, and the U.S. For more information, visit
www.genesiscare.com
